Marrone Bio Innovations (MBII) Stock Price Down 11.3%
Marrone Bio Innovations Inc (NASDAQ:MBII)’s share price fell 11.3% during mid-day trading on Monday . The company traded as low as $1.50 and last traded at $1.57. 585,872 shares traded hands during mid-day trading, an increase of 386% from the average session volume of 120,447 shares. The stock had previously closed at $1.77.
A number of brokerages have recently issued reports on MBII. ValuEngine raised Marrone Bio Innovations from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Zacks Investment Research cut Marrone Bio Innovations from a “hold” rating to a “sell” rating in a report on Thursday, February 15th. Finally, HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the stock a “buy” rating in a report on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $2.50.
The company has a quick ratio of 0.36, a current ratio of 0.69 and a debt-to-equity ratio of -1.14.
TRADEMARK VIOLATION NOTICE: “Marrone Bio Innovations (MBII) Stock Price Down 11.3%” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2018/03/14/marrone-bio-innovations-mbii-stock-price-down-11-3.html.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.